Panacea Biotec reaches settlement with Apotex
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
The FDA set a target action date of April 28, 2026, under the Prescription Drug User Fee Act
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
Subscribe To Our Newsletter & Stay Updated